Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03179306 · ClinicalTrials.gov registry record
Cervix Image Sharing Protocol (CISP)
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 27,084
- Enrollment target
NCT03179306: Completed study, sponsored by National Cancer Institute (NCI).
NCT03179306 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 27,084 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03179306 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 27,084 participants
- Enrollment target
Study Summary
The Clinical Epidemiology Unit in the Clinical Genetics Branch of the Division of Cancer Epidemiology, NCI has a strong interest in fostering cervical cancer prevention solutions for all kinds of settings, including lowresource ones that rely on development of robust, low-cost screening and triage tools. Therefore, to support development of algorithms for cervical image recognition software, NCI seeks to share digital cervical images and accompanying clinical data from our large epidemiological studies on HPV and cervical cancer screening with interested and qualified image analysis researchers. To accommodate the many researchers that are interested, we have created this standard protocol to describe a unified process for sharing deidentified cervical images and accompanying de-identified clinical data from the following NCI studies: Costa Rican Natural History Study of HPV and Cervical Neoplasia , ASCUS LSIL Triage Study-- ALTS , SUCCEED and Costa Rica Vaccine Trial .
Primary Outcome
The identification of CIN3 or cancer in histopathology analyses of biopsy and cervical excisional specimens.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27,084 participants |
| Start Date | 2017-05-15 |
| Est. Completion | 2020-04-22 |
What the finished NCT03179306 record still lists
NCT03179306 is an observational study that tracks outcomes without assigning an intervention. Its 27,084 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT03179306 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03179306 about?
NCT03179306 is a clinical study titled "Cervix Image Sharing Protocol (CISP)". The Clinical Epidemiology Unit in the Clinical Genetics Branch of the Division of Cancer Epidemiology, NCI has a strong interest in fostering cervical cancer prevention solutions for all kinds of settings, including lowresource ones that rely on development of robust, low-cost screening and triage t...
What is the current status of trial NCT03179306?
This trial is currently completed. The enrollment target is 27,084 participants. The study started on 2017-05-15. Estimated completion is 2020-04-22.
Who is sponsoring clinical trial NCT03179306?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04678193 · 27,000 participants
COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy
- NCT04494945 · 27,500 participants · NA
Identifying and Caring for Individuals With Inherited Cancer Syndrome
- NCT07300839 · 25,500 participants · Phase 3
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
- NCT03175302 · 25,240 participants
PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI